The antibody simtuzumab, targeting extracellular LOXL2, has undergone clinical trials in combination with gemcitabine for patients with metastatic pancreatic adenocarcinoma or with FOLFIRI (folinic acid, fluorouracil, and irinotecan) for patients with KRAS mutant colorectal cancer [102, 103]
Patients with kidney disease, cancer, or other chronic conditions may not be eligible for peptide therapy
muddy Use a freshly opened, new needle and syringe for every injection
Cagrilintide 10mg provides researchers with access to this important amylin analogue for comparative studies
TB-500 (Thymosin Beta-4 Fragment) TB-500 peptide is a synthetic version of a fragment of thymosin beta-4, often discussed for its role in cellular migration and tissue regeneration